# Plain Language Summary: Harm Reduction Through Community Engagement Act of 2023

This bill changes how the federal government approves opioid treatment clinics—places where people receive medication and counseling for opioid addiction. Right now, the government mainly checks if a clinic meets basic medical standards. This bill adds a requirement that clinics must actively engage with their local communities and prove they're actually needed before opening or staying open.

The main changes affect opioid treatment programs that provide maintenance treatment (like methadone clinics) or detoxification services. Before getting approved, clinics must now do several things: conduct community outreach to explain what they'll do, create a neighborhood engagement plan showing how they'll work with local groups, and establish a community advisory board with volunteers from the neighborhood. They also have to develop a plan to handle quality-of-life problems like loitering, discarded needles, and open drug use near the clinic. Additionally, clinics must be located at least half a mile away from schools, daycare centers, playgrounds, and other treatment facilities.

The bill also requires clinics to promote telehealth appointments so fewer patients need to physically visit the location, and to track data on how many people actually seek long-term treatment and whether telehealth is working. Every year, the federal government must report to Congress on how well these community engagement efforts are working and share best practices for keeping clinics and neighborhoods working together effectively.

Essentially, this bill tries to balance two goals: making sure people with opioid addiction can access treatment, while also giving communities a real voice in where and how these clinics operate and ensuring they're solving problems rather than creating new ones.

Harm Reduction Through Community Engagement Act of 2023

Rep. Espaillat, Adriano [D-NY-13]

Harm Reduction Through Community Engagement Act of 2023 This bill requires opioid treatment programs to meet additional conditions related to community engagement, location, and other matters to be registered to dispense controlled substances for treating opioid use disorders. In particular, treatment programs must engage with the surrounding community to address concerns and mitigate any negative impacts of the treatment program on the community. This includes establishing a community advisory board and implementing a community relations plan. Additionally, treatment programs may not provide treatment services near specified locations frequented by children (e.g., elementary schools, day cares, and playgrounds) or another drug treatment facility or program. The bill also requires treatment programs to actively promote the use of telehealth to minimize the need for in-person treatment.